JOINT FILING AGREEMENTJoint Filing Agreement • July 20th, 2021 • Arix Bioscience PLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, $0.001 par value per share, of Imara Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to Such Statement.
